Spyre Therapeutics, Inc. - Company Filings ↗
| cik | 0001636282 |
| entityType | operating |
| sic | 2834 |
| sicDescription | Pharmaceutical Preparations |
| ownerOrg | 03 Life Sciences |
| insiderTransactionForOwnerExists | 0 |
| insiderTransactionForIssuerExists | 1 |
| name | Spyre Therapeutics, Inc. |
| tickers | SYRE |
| exchanges | Nasdaq |
| ein | 464312787 |
| lei | — |
| description | — |
| website | — |
| investorWebsite | — |
| category | Large accelerated filer |
| fiscalYearEnd | 1231 |
| stateOfIncorporation | DE |
| stateOfIncorporationDescription | DE |
| addresses.mailing | street1: 221 CRESCENT STREET street2: BUILDING 23, SUITE 105 city: WALTHAM stateOrCountry: MA zipCode: 02453 stateOrCountryDescription: MA isForeignLocation: 0 |
| addresses.business | street1: 221 CRESCENT STREET street2: BUILDING 23, SUITE 105 city: WALTHAM stateOrCountry: MA zipCode: 02453 stateOrCountryDescription: MA |
| phone | 6176515940 |
| flags | — |
| formerNames | name: Aeglea BioTherapeutics, Inc., from: 2015-03-24T04:00:00.000Z, to: 2023-11-24T05:00:00.000Z |